Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
928.60
-7.75 (-0.83%) Zydus Lifesciences informs about buyback offer
Date: 20-06-2022Zydus Lifesciences has informed that it submitted the Public Announcement, Draft Letter of Offer and Letter of Offer, respectively, pertaining to the Buyback. The company also enclosed the copy of the offer opening advertisement dated June 18, 2022 pertaining to the Buyback which has been published on June 20, 2022 in the following newspapers: Financial Express-English- All edition; Jansatta-Hindi-All edition; Financial Express-Gujarati- Ahmedabad edition.
The above information is a part of company’s filings submitted to BSE.